Beam Therapeutics (BEAM) Shares Outstanding (Diluted) (2019 - 2026)
Beam Therapeutics (BEAM) reported Weighted Average Shares Outstanding (Diluted) of 104.7 million for Q3 2026, up 2.1% from 102.57 million a year earlier and up 0.4% from the prior quarter.
Powered by 
Analysis
Beam Therapeutics (BEAM) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends
For FY2025, Beam Therapeutics posted Weighted Average Shares Outstanding (Diluted) of 98.91 million, up 20.2% from FY2024.
- Weighted Average Shares Outstanding (Diluted) has increased for six consecutive years, with a five-year compound annual growth rate of 16.2% (FY2020 to FY2025).
- By year, Weighted Average Shares Outstanding (Diluted) came in at 82.31 million in FY2024 (+6.7%), 77.15 million in FY2023 (+10.2%), 70.02 million in FY2022 (+9.0%) and 64.23 million in FY2021 (+37.4%).
- The Q3 2026 figure ranks as the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q4 2019.
- Year over year, Weighted Average Shares Outstanding (Diluted) has now increased in each of the last 24 quarters, with growth averaging 13.1% over the last eight quarters.
- The year-over-year growth in Weighted Average Shares Outstanding (Diluted) has ranged between 2.1% (Q3 2026) and 37.4% (Q4 2021) over the last five years.
- Per Business Quant data, the three quarters before Q3 2026 came in at 104.33 million (Q2 2026), 103.26 million (Q1 2026) and 98.91 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Beam Therapeutics | 2.60 Bn | -2.05 Bn | - | 104.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 104.70 Mn |
| Jun 30, 2026 | 104.33 Mn |
| Mar 31, 2026 | 103.26 Mn |
| Dec 31, 2025 | 98.91 Mn |
| Sep 30, 2025 | 102.57 Mn |
| Jun 30, 2025 | 102.00 Mn |
| Mar 31, 2025 | 87.98 Mn |
| Dec 31, 2024 | 82.31 Mn |
| Sep 30, 2024 | 82.41 Mn |
| Jun 30, 2024 | 82.31 Mn |
| Mar 31, 2024 | 81.70 Mn |
| Dec 31, 2023 | 77.15 Mn |
| Sep 30, 2023 | 79.02 Mn |
| Jun 30, 2023 | 76.34 Mn |
| Mar 31, 2023 | 72.27 Mn |
| Dec 31, 2022 | 70.02 Mn |
| Sep 30, 2022 | 70.34 Mn |
| Jun 30, 2022 | 70.21 Mn |
| Mar 31, 2022 | 68.70 Mn |
| Dec 31, 2021 | 64.23 Mn |
API Access
Beam Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=BEAM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "BEAM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=BEAM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();